Search Results - "Bodo, J."

Refine Results
  1. 1

    MCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K/AKT/mTOR activation in lymphoid malignancies by Choudhary, G S, Al-harbi, S, Mazumder, S, Hill, B T, Smith, M R, Bodo, J, Hsi, E D, Almasan, A

    Published in Cell death & disease (01-01-2015)
    “…Overexpression of anti-apoptotic BCL-2 family members is a hallmark of many lymphoid malignancies, including chronic lymphocytic leukemia (CLL) and non-Hodgkin…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Anti-inflammatory and anti-arthritic activity of a methanol extract from Vitellaria paradoxa stem bark by Foyet, Harquin, Tsala, David, Zogo Essono Bodo, J, Carine, Azanfack, Heroyne, Lissia, Oben, Eyong

    Published in Pharmacognosy research (01-10-2015)
    “…Background: Vitellaria paradoxa is a traditional medicinal plant of Cameroon. Several studies on this plant have focused on the cosmetic profile of its fruits…”
    Get full text
    Journal Article
  4. 4

    CpG methylation patterns and decitabine treatment response in acute myeloid leukemia cells and normal hematopoietic precursors by Negrotto, S, Ng, K P, Jankowska, A M, Bodo, J, Gopalan, B, Guinta, K, Mulloy, J C, Hsi, E, Maciejewski, J, Saunthararajah, Y

    Published in Leukemia (01-02-2012)
    “…The DNA hypomethylating drug decitabine maintains normal hematopoietic stem cell (HSC) self-renewal but induces terminal differentiation in acute myeloid…”
    Get full text
    Journal Article
  5. 5

    The adult penile urethra is a novel entry site for HIV-1 that preferentially targets resident urethral macrophages by Ganor, Y, Zhou, Z, Bodo, J, Tudor, D, Leibowitch, J, Mathez, D, Schmitt, A, Vacher-Lavenu, M-C, Revol, M, Bomsel, M

    Published in Mucosal immunology (01-07-2013)
    “…The penile urethra is routinely targeted by sexually transmitted bacterial and viral pathogens, and also represents a probable site for HIV type-1 (HIV-1)…”
    Get full text
    Journal Article
  6. 6

    Higher frequency of genetic variants conferring increased risk for ADRs for commonly used drugs treating cancer, AIDS and tuberculosis in persons of African descent by Aminkeng, F, Ross, C J D, Rassekh, S R, Brunham, L R, Sistonen, J, Dube, M-P, Ibrahim, M, Nyambo, T B, Omar, S A, Froment, A, Bodo, J-M, Tishkoff, S, Carleton, B C, Hayden, M R

    Published in The pharmacogenomics journal (01-04-2014)
    “…There is established clinical evidence for differences in drug response, cure rates and survival outcomes between different ethnic populations, but the causes…”
    Get full text
    Journal Article
  7. 7

    Identification of Ezrin-Radixin-Moesin proteins as novel regulators of pathogenic B-cell receptor signaling and tumor growth in diffuse large B-cell lymphoma by Pore, D, Bodo, J, Danda, A, Yan, D, Phillips, J G, Lindner, D, Hill, B T, Smith, M R, Hsi, E D, Gupta, N

    Published in Leukemia (01-09-2015)
    “…Diffuse large B-cell lymphoma (DLBCL) is a hematological cancer associated with an aggressive clinical course. The predominant subtypes of DLBCL display…”
    Get full text
    Journal Article
  8. 8

    Clinicopathologic and molecular characterization of myeloid neoplasms with isolated t(6;9)(p23;q34) by Visconte, V., Shetty, S., Przychodzen, B., Hirsch, C., Bodo, J., Maciejewski, J. P., Hsi, E. D., Rogers, H. J.

    “…Summary Introduction The t(6;9)(p23;q34);DEK‐NUP214 [t(6;9)] abnormality is found in 0.7–1.8% of patients with acute myeloid leukemia (AML) or myelodysplastic…”
    Get full text
    Journal Article
  9. 9

    Phosphoproteins and the dawn of functional phenotyping by Bodo, J, Hsi, E D

    Published in Pathobiology (Basel) (01-01-2011)
    “…Phosphorylation is one of the most important processes in cell signal transduction. Detection of phosphorylated proteins in cancer tissue is useful for…”
    Get more information
    Journal Article
  10. 10

    Sensitisation for cisplatin-induced apoptosis by isothiocyanate E-4IB leads to signalling pathways alterations by BODO, J, HUNAKOVA, L, KVASNICKA, P, JAKUBIKOVA, J, DURAJ, J, KASPARKOVA, J, SEDLAK, J

    Published in British journal of cancer (20-11-2006)
    “…A new synthetic isothiocyanate (ITC) derivative, ethyl 4-isothiocyanatobutanoate (E-4IB), appeared to be an effective modulator of cellular proliferation and…”
    Get full text
    Journal Article
  11. 11

    Flavonoid quercetin, but not apigenin or luteolin, induced apoptosis in human myeloid leukemia cells and their resistant variants by Duraj, J, Zazrivcova, K, Bodo, J, Sulikova, M, Sedlak, J

    Published in Neoplasma (2005)
    “…Flavonoids and their in vivo metabolites are neuroprotective, cardioprotective and chemopreventive agents acting as hydrogen-donating antioxidants or…”
    Get more information
    Journal Article
  12. 12

    Isothiocyanate E-4IB induces MAPK activation, delayed cell cycle transition and apoptosis by Bodo, J., Duraj, J., Jakubikova, J., Sedlak, J.

    Published in Cell proliferation (01-06-2007)
    “…  Introduction: Epidemiologic studies point towards a significant correlation between the dietary intake of isothiocyanate‐containing foods and the reduced…”
    Get full text
    Journal Article
  13. 13

    Enhanced sensitivity of human ovarian carcinoma cell lines A2780 and A2780/CP to the combination of cisplatin and synthetic isothiocyanate ethyl 4-isothiocyanatobutanoate by Bodo, J, Chovancova, J, Hunakova, L, Sedlak, J

    Published in Neoplasma (2005)
    “…Naturally occurring and synthetic isothiocyanates (ITCs) are known as chemopreventive agents. The present study shows a new synthetic ITC derivate ethyl…”
    Get more information
    Journal Article
  14. 14

    Administration of isothiocyanate (E-4IB) and cisplatin leads to altered signalling and lysosomal export in human ovarian carcinoma sensitive- and cisplatin-resistant cells by Duraj, J, Hunakova, L, Bodo, J, Jakubikova, J, Chovancova, J, Sedlak, J

    Published in Neoplasma (2009)
    “…The aim of this study was to compare the effect of a new synthetic isothiocyanate derivative, ethyl 4-isothiocyanatobutanoate (E-4IB) and cisplatin (CDDP) in…”
    Get more information
    Journal Article
  15. 15

    Expression of new prognostic markers, peripheral-type benzodiazepine receptor and carbonic anhydrase IX, in human breast and ovarian carcinoma cell lines by Hunakova, L, Bodo, J, Chovancova, J, Sulikova, G, Pastorekova, S, Sedlak, J

    Published in Neoplasma (2007)
    “…Peripheral benzodiazepine receptor (PBR), a mitochondrial protein involved in cell proliferation and differentiation, and carbonic anhydrase IX (CA IX), an…”
    Get more information
    Journal Article
  16. 16

    Characterization of trypanosome infections by polymerase chain reaction (PCR) amplification in wild tsetse flies in Cameroon by Morlais, I, Grebaut, P, Bodo, J M, Djoha, S, Cuny, G

    Published in Parasitology (01-06-1998)
    “…The polymerase chain reaction (PCR) method was used to characterize trypanosome infections in tsetse flies from 3 sleeping sickness foci in Cameroon. The…”
    Get more information
    Journal Article
  17. 17

    Isothiocyanate iberin modulates phase II enzymes, posttranslational modification of histones and inhibits growth of Caco-2 cells by inducing apoptosis by Jakubikova, J, Bao, Y, Bodo, J, Sedlak, J

    Published in Neoplasma (2006)
    “…The aim of presented study was to further investigate the concentration-dependent changes induced by isothiocyanate iberin (IBN) in human colon carcinoma…”
    Get more information
    Journal Article
  18. 18

    Detection and identification of trypanosomes by polymerase chain reaction in wild tsetse flies in Cameroon by Morlais, I, Grebaut, P, Bodo, J.M, Djoha, S, Cuny, G, Herder, S

    Published in Acta tropica (15-06-1998)
    “…The prevalence of various species and subgroups of trypanosomes in infected flies from three sleeping sickness foci in Cameroon was determined by the use of…”
    Get full text
    Journal Article
  19. 19

    A novel sickle cell mutation by yet another origin in Africa : the Cameroon type by LAPOUMEROULIE, C, DUNDA, O, DUCROCQ, R, TRABUCHET, G, MONY-LOBE, M, BODO, J. M, CARNEVALE, P, LABIE, D, ELION, J, KRISHNAMOORTHY, R

    Published in Human genetics (01-05-1992)
    “…The sickle cell mutation (beta s) arose as at least three independent events in Africa and once in Asia, being termed the Senegal, Benin, Bantu and Indian…”
    Get full text
    Journal Article
  20. 20

    Association between circulating CCL2 levels and modifiable behaviors in overweight and obese adolescents: a cross-sectional pilot study by Bodo, Mackenzie J, Jimenez, Elizabeth Yakes, Conn, Carole, Dye, Alyssa, Pomo, Page, Kolkmeyer, Deborah, Orlando, Robert, Kong, Alberta S

    “…We evaluated the relationship between an early inflammatory biomarker, chemokine (C-C motif) ligand 2 (CCL2), and other clinical biomarkers and lifestyle…”
    Get more information
    Journal Article